Back pain and comorbidity - diagnostics, therapeutic tactics
Abstract
The pain in the lower back the treatment of which remains one of the priority directions of the modern medicine is a heavy burden for patients as well as for the healthcare on the whole. In our country pan in the lower back accounts for 76% of all cases of application for medical aid and 72% of days of temporary incapacity to labour in the outpatient-polyclinic network [1].
Keywords
коморбидные больные,
боль в спине,
лечение,
НПВП,
Найзилат,
comorbid patients,
back pain,
therapy,
NSAIF,
Niselat
About the Authors
N. A. Shostak
Pirogov Russian Scientific and Research Medical University
Russian Federation
Russian Federation
N. G. Pravdyuk
Pirogov Russian Scientific and Research Medical University
Russian Federation
Russian Federation
References
1. Кокина М.С., Филатова Е.Г. Анализ причин неудачного хирургического лечения пациентов с болью в спине. Неврология, нейропсихиатрия, психосоматика, 2011, 3: 30-34.
2. Chiodo AE et al. UMHS Low Back Pain Guideline Update, January 2010.
3. Hochberg MC, Silman AJ, Smolen JS et al. Rheumatology, 2015, 2(6): 1976.
4. Hooten WM, Cohen SP. Evaluation and Treatment of Low Back Pain A Clinically Focused Review for Primary Care Specialists. Mayo Clin Proc, 2015, 90(12): 1699-1718.
5. Шостак Н.А., Правдюк Н.Г. Боль в спине у пожилых - подходы к диагностике и лечению. Клиницист, 2011, 3: 73-77.
6. Ha IH, Lee J, Kim MR et al. The association between the history of cardiovascular diseases and chronic low back pain in South Koreans: a cross-sectional study. PLOS ONE, 2014, 9(4): e93671.
7. Schofield DJ, Callander EJ, Shrestha RN et al. Association between co-morbidities and labour force participation amongst persons with back problems. Pain, 2012, 153: 2058-2072.
8. Bauer UE, Briss PA, Goodman RA et al. Prevention of chronic disease in the 21st century: elimination of the leading preventable causes of premature death and disability in the USA. Lancet, 2014, 384: 45-52.
9. Электронный ресурс: http://www.aihw.gov.au/back-problems/associated-comorbidities-and-risk-factors/overview/, цит. 2.09.2016.
10. Ширинский В.С. и соавт. Коморбидные заболевания - актуальная проблема клинической медицины. Сиб. Медицинский Журнал, 2014.
11. Белялов Ф.И. Лечение внутренних болезней в условиях коморбидности: монография. 7-е изд., перераб. и доп. Иркутск: РИО ИГИУВа, 2011. 305 с.
12. Шостак Н.А., Клименко А.А. Нестероидные противовоспалительные препараты - современные аспекты их применения. Клиницист, 2013, 3-4: 53-61.
13. Шостак Н.А., Мурадянц А.А. Ревматоидный артрит: клинические ситуации и алгоритмы лечения. РМЖ, 2016, 2: 89-95.
14. Шостак Н.А., Правдюк Н.Г. Боль в спине как модель болевого синдрома смешанного генеза. РМЖ, 2015, 17: 1020.
15. Marcolongo R, Frediani B, Biasi G et al. Metanalysis of the tolerability of amtolmetin-guacyl, a new, efficacious, non-steroidal anti-inflammatory drug, compared with traditional NSAIDs. Clin Drug Inves, 1999, 17: 89-96.
Review
For citations:
Shostak N.A., Pravdyuk N.G. Back pain and comorbidity - diagnostics, therapeutic tactics. Ambulatornaya khirurgiya = Ambulatory Surgery (Russia). 2016;(3-4):44-50. (In Russ.)
Views:
832
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International.
Email this article 